Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery

Michael S. Lee, James R. Wilentz, Raj R. Makkar, Varinder Singh, Tom Nero, Daniel Swistel, Scott J. Belsey, Claude Simon, Salvatore Rametta, Joseph DeRose

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Hybrid revascularization (HR) combines staged percutaneous coronary intervention (PCI) on stenoses in the non-left anterior descending (LAD) territories with minimally invasive direct coronary artery bypass (MIDCAB) using the left internal thoracic artery (LITA) to the LAD. The LITA-to-LAD graft, which has a 5-year patency rate of 95%, is the major determinant of the long-term survival for patients. Thus, HR aims to perform full revascularization without compromising the survival advantage of the LITA-to-LAD graft, while preserving the minimally invasive advantages associated with the percutaneous treatment of symptomatic coronary stenoses. We investigated whether HR was a valid alternative to conventional coronary artery bypass graft surgery in patients with multivessel coronary artery disease. We also present our early experiences with HR using a combined approach of advanced PCI and robotically-assisted MIDCAB.

Original languageEnglish (US)
Pages (from-to)419-425
Number of pages7
JournalJournal of Invasive Cardiology
Volume16
Issue number8
StatePublished - Aug 2004
Externally publishedYes

Fingerprint

Mammary Arteries
Percutaneous Coronary Intervention
Coronary Artery Bypass
Transplants
Survival
Coronary Stenosis
Coronary Artery Disease
Pathologic Constriction
Therapeutics

Keywords

  • CABG versus PCI
  • New devices

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery. / Lee, Michael S.; Wilentz, James R.; Makkar, Raj R.; Singh, Varinder; Nero, Tom; Swistel, Daniel; Belsey, Scott J.; Simon, Claude; Rametta, Salvatore; DeRose, Joseph.

In: Journal of Invasive Cardiology, Vol. 16, No. 8, 08.2004, p. 419-425.

Research output: Contribution to journalArticle

Lee, MS, Wilentz, JR, Makkar, RR, Singh, V, Nero, T, Swistel, D, Belsey, SJ, Simon, C, Rametta, S & DeRose, J 2004, 'Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery', Journal of Invasive Cardiology, vol. 16, no. 8, pp. 419-425.
Lee, Michael S. ; Wilentz, James R. ; Makkar, Raj R. ; Singh, Varinder ; Nero, Tom ; Swistel, Daniel ; Belsey, Scott J. ; Simon, Claude ; Rametta, Salvatore ; DeRose, Joseph. / Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery. In: Journal of Invasive Cardiology. 2004 ; Vol. 16, No. 8. pp. 419-425.
@article{fa83e05d4a064aa99588a7a722b3e675,
title = "Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery",
abstract = "Hybrid revascularization (HR) combines staged percutaneous coronary intervention (PCI) on stenoses in the non-left anterior descending (LAD) territories with minimally invasive direct coronary artery bypass (MIDCAB) using the left internal thoracic artery (LITA) to the LAD. The LITA-to-LAD graft, which has a 5-year patency rate of 95{\%}, is the major determinant of the long-term survival for patients. Thus, HR aims to perform full revascularization without compromising the survival advantage of the LITA-to-LAD graft, while preserving the minimally invasive advantages associated with the percutaneous treatment of symptomatic coronary stenoses. We investigated whether HR was a valid alternative to conventional coronary artery bypass graft surgery in patients with multivessel coronary artery disease. We also present our early experiences with HR using a combined approach of advanced PCI and robotically-assisted MIDCAB.",
keywords = "CABG versus PCI, New devices",
author = "Lee, {Michael S.} and Wilentz, {James R.} and Makkar, {Raj R.} and Varinder Singh and Tom Nero and Daniel Swistel and Belsey, {Scott J.} and Claude Simon and Salvatore Rametta and Joseph DeRose",
year = "2004",
month = "8",
language = "English (US)",
volume = "16",
pages = "419--425",
journal = "Journal of Invasive Cardiology",
issn = "1042-3931",
publisher = "HMP Communications",
number = "8",

}

TY - JOUR

T1 - Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery

AU - Lee, Michael S.

AU - Wilentz, James R.

AU - Makkar, Raj R.

AU - Singh, Varinder

AU - Nero, Tom

AU - Swistel, Daniel

AU - Belsey, Scott J.

AU - Simon, Claude

AU - Rametta, Salvatore

AU - DeRose, Joseph

PY - 2004/8

Y1 - 2004/8

N2 - Hybrid revascularization (HR) combines staged percutaneous coronary intervention (PCI) on stenoses in the non-left anterior descending (LAD) territories with minimally invasive direct coronary artery bypass (MIDCAB) using the left internal thoracic artery (LITA) to the LAD. The LITA-to-LAD graft, which has a 5-year patency rate of 95%, is the major determinant of the long-term survival for patients. Thus, HR aims to perform full revascularization without compromising the survival advantage of the LITA-to-LAD graft, while preserving the minimally invasive advantages associated with the percutaneous treatment of symptomatic coronary stenoses. We investigated whether HR was a valid alternative to conventional coronary artery bypass graft surgery in patients with multivessel coronary artery disease. We also present our early experiences with HR using a combined approach of advanced PCI and robotically-assisted MIDCAB.

AB - Hybrid revascularization (HR) combines staged percutaneous coronary intervention (PCI) on stenoses in the non-left anterior descending (LAD) territories with minimally invasive direct coronary artery bypass (MIDCAB) using the left internal thoracic artery (LITA) to the LAD. The LITA-to-LAD graft, which has a 5-year patency rate of 95%, is the major determinant of the long-term survival for patients. Thus, HR aims to perform full revascularization without compromising the survival advantage of the LITA-to-LAD graft, while preserving the minimally invasive advantages associated with the percutaneous treatment of symptomatic coronary stenoses. We investigated whether HR was a valid alternative to conventional coronary artery bypass graft surgery in patients with multivessel coronary artery disease. We also present our early experiences with HR using a combined approach of advanced PCI and robotically-assisted MIDCAB.

KW - CABG versus PCI

KW - New devices

UR - http://www.scopus.com/inward/record.url?scp=4143125670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143125670&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 419

EP - 425

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 8

ER -